2,654
edits
Inspections/Investigations by Third Parties: Difference between revisions
Inspections/Investigations by Third Parties (view source)
Revision as of 11:14, February 18, 2020
, February 18, 2020no edit summary
(changed Clinical Trial Professional and Technical Fee Billing to Clinical Research and Clinical Trial Professional and Technical Fee Billing so link would be bold and black when on the page) |
mNo edit summary |
||
| Line 19: | Line 19: | ||
</table> | </table> | ||
<br /> | <br /> | ||
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[International | [[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[Disclosing Foreign Support and International Activities]] | [[Health Care Vendor Interactions]] | [[Credit Hour Definition]] | [[Whistleblower]]<br /> | ||
<br /><br /> | <br /> | ||
Policy No.: '''6109'''<br /> | Policy No.: '''6109'''<br /> | ||
Effective Date: '''10/16/04'''<br /> | Effective Date: '''10/16/04'''<br /> | ||
Revised Date: '''02/12/18'''<br /> | Revised Date: '''02/12/18'''<br /> | ||
Reviewed Date: '''02/12/18'''<br /><br \> | Reviewed Date: '''02/12/18'''<br /><br \> | ||
'''<big>Investigations by Government Officials, Regulatory Agencies, and Other Third Parties</big>''' | '''<big>Investigations by Government Officials, Regulatory Agencies, and Other Third Parties</big>'''<br /><br \> | ||
<br /><br \> | |||
== Purpose == | == Purpose == | ||
Government investigators, regulatory agencies or other third parties may contact staff or arrive unannounced at UNMC or at the homes of staff members and seek interviews, documents, information or request to search the premises. The purpose of this policy is to establish procedures for an orderly response that protects the interests of UNMC and provides for appropriate cooperation. Examples of regulatory agency visits, investigations, or requests for information that are subject to this policy include but are not limited to the following: | Government investigators, regulatory agencies or other third parties may contact staff or arrive unannounced at UNMC or at the homes of staff members and seek interviews, documents, information or request to search the premises. The purpose of this policy is to establish procedures for an orderly response that protects the interests of UNMC and provides for appropriate cooperation. Examples of regulatory agency visits, investigations, or requests for information that are subject to this policy include but are not limited to the following: | ||
| Line 60: | Line 59: | ||
*Associate General Counsel for Health Sciences, 402-559-9005 | *Associate General Counsel for Health Sciences, 402-559-9005 | ||
*[https://support.security.unmc.edu Office of Information Security] | *[https://support.security.unmc.edu Office of Information Security] | ||
This page maintained by [mailto:dpanowic@unmc.edu dkp]. | This page maintained by [mailto:dpanowic@unmc.edu dkp]. | ||